Plant ID: NPO3102
Plant Latin Name: Arachniodes Exilis
Taxonomy Genus: Arachniodes
Taxonomy Family: Dryopteridaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
Ingredient ID: NPC95126
Ingredient ID: NPC94939
Ingredient ID: NPC94045
Ingredient ID: NPC93829
Ingredient ID: NPC9129
Ingredient ID: NPC9007
Ingredient ID: NPC83287
Ingredient ID: NPC56854
Ingredient ID: NPC50855
Ingredient ID: NPC41845
Ingredient ID: NPC4152
Ingredient ID: NPC38807
Ingredient ID: NPC37592
Ingredient ID: NPC369
Ingredient ID: NPC35543
Ingredient ID: NPC32021
Ingredient ID: NPC303032
Ingredient ID: NPC2989
Ingredient ID: NPC293831
Ingredient ID: NPC283700
Ingredient ID: NPC269923
Ingredient ID: NPC265513
Ingredient ID: NPC243083
Ingredient ID: NPC236777
Ingredient ID: NPC234337
Ingredient ID: NPC2290
Ingredient ID: NPC216630
Ingredient ID: NPC209970
Ingredient ID: NPC19256
Ingredient ID: NPC189468
Ingredient ID: NPC189078
Ingredient ID: NPC183339
Ingredient ID: NPC181782
Ingredient ID: NPC176308
Ingredient ID: NPC171736
Ingredient ID: NPC15999
Ingredient ID: NPC149184
Ingredient ID: NPC141836
Ingredient ID: NPC133389
Ingredient ID: NPC130683
Ingredient ID: NPC104551
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Therapeutic Target | Enzyme | KARS1 | Lysyl-tRNA synthetase | Q15046 | CHEMBL5575 |
Therapeutic Target | Fatty acid binding protein family | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Therapeutic Target | Transcription factor | KLF5 | Kruppel-like factor 5 | Q13887 | CHEMBL1293249 |
Therapeutic Target | Unclassified protein | GMNN | Geminin | O75496 | CHEMBL1293278 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 139 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT02303795 | RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial | heart disease | Warfarin (NPC2989) | NP level |
NCT02832544 | INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority | rheumatic heart disease | Warfarin (NPC2989) | NP level |
NCT03839355 | Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00448214 | Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00689637 | Drug Interaction Study Between AZD3480 and Warfarin | Alzheimer disease | Warfarin (NPC2989) | NP level |
NCT01462318 | An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis | relapsing-remitting multiple sclerosis | Warfarin (NPC2989) | NP level |
NCT02283294 | Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation | stroke | Warfarin (NPC2989) | NP level |
NCT00643201 | Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism | Venous thrombosis | Warfarin (NPC2989) | NP level |
NCT02772601 | This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis | psoriasis | Warfarin (NPC2989) | NP level |
NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | atrial fibrillation;atrial flutter | Warfarin (NPC2989) | NP level |
NCT00740883 | Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. | pulmonary embolism | Warfarin (NPC2989) | NP level |
NCT01201954 | Pain Relief of Newborn Preterm Infants During Endotracheal Suctioning | pain | Sucrose (NPC130683) | NP level |
NCT04142658 | PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban | aortic stenosis | Warfarin (NPC2989) | NP level |
NCT02174705 | Rotavirus vs. Sucrose for Vaccine Injection Pain | pain | Sucrose (NPC130683) | NP level |
NCT01227629 | PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT03764241 | Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant | thrombotic disease | Warfarin (NPC2989) | NP level |
NCT01006876 | Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT01505881 | Follow on Study From RE-ALIGN | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT03684564 | RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome | antiphospholipid syndrome | Warfarin (NPC2989) | NP level |
NCT01388335 | A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin | lymphoma | Warfarin (NPC2989) | NP level |
NCT00091299 | Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors | neoplasm | Warfarin (NPC2989) | NP level |
NCT00856570 | A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects | overactive bladder | Warfarin (NPC2989) | NP level |
NCT00000614 | Prevention of Recurrent Venous Thromboembolism (PREVENT) | heart disease;peripheral vascular disease;Thromboembolism;venous thromboembolism | Warfarin (NPC2989) | NP level |
NCT02740712 | Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | neoplasm | Warfarin (NPC2989) | NP level |
NCT01263119 | A Study of LY2216684 and Warfarin in Healthy Subjects | major depressive disorder | Warfarin (NPC2989) | NP level |
NCT02169440 | Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin | Parkinson disease | Warfarin (NPC2989) | NP level |
NCT02331095 | Statin Use in Patients With Acute VTE | venous thromboembolism | Warfarin (NPC2989) | NP level |
NCT01516814 | Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients | pulmonary embolism | Warfarin (NPC2989) | NP level |
NCT00007683 | Warfarin and Antiplatelet Therapy in Chronic Heart Failure | heart failure | Warfarin (NPC2989) | NP level |
NCT01431690 | Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals | Hypertriglyceridemia | Warfarin (NPC2989) | NP level |
NCT01695824 | Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT04887194 | PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates | neoplasm | Warfarin (NPC2989) | NP level |
NCT01147731 | A Drug Interaction Study With Albiglutide and Warfarin | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | atrial fibrillation;stroke | Warfarin (NPC2989) | NP level |
NCT00494871 | Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT04002011 | DOAC Versus VKA After Cardiac Surgery | hemorrhage | Warfarin (NPC2989) | NP level |
NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT02070510 | A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects | diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT01662908 | A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis | deep vein thrombosis | Warfarin (NPC2989) | NP level |
NCT01503060 | Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain | pain | Sucrose (NPC130683) | NP level |
NCT03082001 | Sucrose to Reduce Pain During Initiation of Venipuncture in Extremely Low Birth Weight Babies | pain | Sucrose (NPC130683) | NP level |
NCT00519207 | Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborns Undergoing Venipuncture | pain | Sucrose (NPC130683) | NP level |
NCT04994119 | Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics | pulmonary arterial hypertension | Warfarin (NPC2989) | NP level |
NCT00742859 | Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00684307 | Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT01136408 | A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT01507051 | Switching Study From Warfarin to Rivaroxaban | Venous thrombosis | Warfarin (NPC2989) | NP level |
NCT03747081 | Efficacy Comparison of Warfarin Versus Rivaroxaban CVT | Venous thrombosis | Warfarin (NPC2989) | NP level |
NCT00482560 | Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening | pain | Sucrose (NPC130683) | NP level |
NCT02422589 | A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors | neoplasm | Warfarin (NPC2989) | NP level |
NCT04246762 | Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4 | rheumatoid arthritis | Warfarin (NPC2989) | NP level |
NCT00673439 | Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) | Thrombocytopenia | Warfarin (NPC2989) | NP level |
NCT00904176 | Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT00787059 | AC6 Gene Transfer for CHF | congestive heart failure | Sucrose (NPC130683) | NP level |
NCT00329238 | Secondary Prevention of Venous Thrombo Embolism (VTE). | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT00000463 | Post Coronary Artery Bypass Graft (CABG) Study | Myocardial Ischemia | Warfarin (NPC2989) | NP level |
NCT04865978 | Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices | heart failure | Warfarin (NPC2989) | NP level |
NCT01311622 | Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects | rheumatoid arthritis | Warfarin (NPC2989) | NP level |
NCT02544932 | Pleotropic Effect of New Oral Anticoagulants | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00645853 | Long-term Safety in Atrial Fibrillation Patients | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT04569279 | Rivaroxaban vs. Warfarin in CVT Treatment | Venous thrombosis | Warfarin (NPC2989) | NP level |
NCT01287598 | BAY73-4506 Probe Substrate Study | neoplasm | Warfarin (NPC2989) | NP level |
NCT00180674 | Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection | cirrhosis of liver | Warfarin (NPC2989) | NP level |
NCT00949104 | Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates | pain | Sucrose (NPC130683) | NP level |
NCT01518231 | Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke | stroke | Warfarin (NPC2989) | NP level |
NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | atopic eczema | Warfarin (NPC2989) | NP level |
NCT02164864 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT02990364 | Combination Analgesia for Neonatal Circumcision | pain | Sucrose (NPC130683) | NP level |
NCT02072434 | Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF) | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00004728 | Aspirin Or Warfarin To Prevent Stroke | atherosclerosis;cerebral infarction;stroke | Warfarin (NPC2989) | NP level |
NCT02866175 | Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT01432938 | A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT01317927 | A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies | lymphoid neoplasm | Warfarin (NPC2989) | NP level |
NCT05006287 | The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT04066764 | Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters | venous thromboembolism | Warfarin (NPC2989) | NP level |
NCT02397382 | Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis | psoriasis | Warfarin (NPC2989) | NP level |
NCT00125671 | Warfarin and Antiplatelet Vascular Evaluation | peripheral vascular disease | Warfarin (NPC2989) | NP level |
NCT00265408 | Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection | Ischemic stroke | Warfarin (NPC2989) | NP level |
NCT04676035 | The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole | prostate cancer | Warfarin (NPC2989) | NP level |
NCT00218946 | Nasogastric Tube in Premature Babies - Pain and Treatment | premature birth | Sucrose (NPC130683) | NP level |
NCT01190995 | Role of Repeated Painful Procedures in Preterm Neonates on Short Term Neurobehavioural Outcome | pain | Sucrose (NPC130683) | NP level |
NCT02059785 | Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke | Ischemic stroke | Pinocembrin (NPC243083) | NP level |
NCT00973323 | BAY59-7939 Japanese in Atrial Fibrillation (2nd) | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT02287415 | The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin | epilepsy | Warfarin (NPC2989) | NP level |
NCT00291330 | Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT00580216 | Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT01517399 | Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | neoplasm | Warfarin (NPC2989) | NP level |
NCT03745963 | The Influence of Skin-to-skin Contact on Cortical Activity During Painful Procedures on Preterm Infants in the NICU | pain | Sucrose (NPC130683) | NP level |
NCT01238471 | Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study | retinopathy of prematurity | Sucrose (NPC130683) | NP level |
NCT01636557 | A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Warfarin (NPC2989) | NP level |
NCT00914667 | The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects | overactive bladder | Warfarin (NPC2989) | NP level |
NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Warfarin (NPC2989) | NP level |
NCT03217448 | The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis | Venous thrombosis | Warfarin (NPC2989) | NP level |
NCT02492230 | Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI | myocardial infarction | Warfarin (NPC2989) | NP level |
NCT01561547 | Trial of Repeated Analgesia With Kangaroo Care | pain | Sucrose (NPC130683) | NP level |
NCT00726726 | Drug Interaction Study With a Potential Alzheimer's Disease Compound | Alzheimer disease | Warfarin (NPC2989) | NP level |
NCT05208398 | Apixaban in Patients With Left Ventricular Thrombus | thrombotic disease | Warfarin (NPC2989) | NP level |
NCT02450682 | Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00070655 | Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT00216866 | The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis | venous thromboembolism | Warfarin (NPC2989) | NP level |
NCT01130025 | Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | venous thromboembolism | Warfarin (NPC2989) | NP level |
NCT02913326 | A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT00238667 | To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection | stroke | Warfarin (NPC2989) | NP level |
NCT01036802 | Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease | pulmonary hypertension | Warfarin (NPC2989) | NP level |
NCT00404274 | A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers | Chemotherapy-induced nausea and vomiting | Warfarin (NPC2989) | NP level |
NCT01103609 | Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT02022254 | Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects | type 2 diabetes mellitus | Warfarin (NPC2989) | NP level |
NCT00235248 | Aortic Arch Related Cerebral Hazard Trial (ARCH) | brain infarction;transient ischemic attack | Warfarin (NPC2989) | NP level |
NCT00062803 | SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism | pulmonary embolism | Warfarin (NPC2989) | NP level |
NCT00041938 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial | coronary artery disease;myocardial infarction;stroke | Warfarin (NPC2989) | NP level |
NCT04972396 | ALT-801 DDI Study in Healthy Volunteers | non-alcoholic steatohepatitis | Warfarin (NPC2989) | NP level |
NCT03426033 | Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin | cardiovascular disease | Warfarin (NPC2989) | NP level |
NCT00973245 | BAY59-7939 in Atrial Fibrillation Once Daily (OD) | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT04855266 | Iron Sucrose in Patients With Iron Deficiency and POTS | orthostatic hypotension | Sucrose (NPC130683) | NP level |
NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | atrial fibrillation;stroke | Warfarin (NPC2989) | NP level |
NCT02305030 | Effect of Opicapone at Steady State on Warfarin Pharmacokinetics | Parkinson disease | Warfarin (NPC2989) | NP level |
NCT03147638 | Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) | Thrombocytopenia | Warfarin (NPC2989) | NP level |
NCT05445232 | A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants | obesity | Warfarin (NPC2989) | NP level |
NCT00001713 | Treatment for Blood Clots in the Veins of the Legs | Thrombophlebitis | Warfarin (NPC2989) | NP level |
NCT01516840 | Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients | deep vein thrombosis | Warfarin (NPC2989) | NP level |
NCT02086864 | A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD | attention deficit hyperactivity disorder | Sucrose (NPC130683) | NP level |
NCT01911728 | Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates | prostate cancer | Warfarin (NPC2989) | NP level |
NCT03272594 | The Influence of Breastfeeding on Cortical Activity During Procedures | pain | Sucrose (NPC130683) | NP level |
NCT04727437 | STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism | pulmonary embolism | Warfarin (NPC2989) | NP level |
NCT02426060 | A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers | osteoarthritis | Warfarin (NPC2989) | NP level |
NCT00957242 | AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis | idiopathic pulmonary fibrosis | Warfarin (NPC2989) | NP level |
NCT00680186 | Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) | Thromboembolism | Warfarin (NPC2989) | NP level |
NCT03718507 | Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants | acute respiratory distress syndrome | Sucrose (NPC130683) | NP level |
NCT03358706 | A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis | Crohn's disease;ulcerative colitis | Warfarin (NPC2989) | NP level |
NCT01340846 | A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | cancer | Warfarin (NPC2989) | NP level |
NCT00027066 | Warfarin Versus Aspirin Recurrent Stroke Study | stroke | Warfarin (NPC2989) | NP level |
NCT00345618 | Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach | thrombotic disease | Warfarin (NPC2989) | NP level |
NCT00938132 | A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers | essential hypertension | Warfarin (NPC2989) | NP level |
NCT02238535 | Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension | pulmonary arterial hypertension | Warfarin (NPC2989) | NP level |
NCT03536208 | Biological Effect of Warfarin on Pancreatic Cancer | pancreatic carcinoma | Warfarin (NPC2989) | NP level |
NCT00938730 | A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation | atrial fibrillation | Warfarin (NPC2989) | NP level |
NCT01769768 | Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients | neoplasm | Warfarin (NPC2989) | NP level |
NCT01758640 | Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy | pregnancy | Warfarin (NPC2989) | NP level |
NCT02647086 | Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) | atopic eczema | Warfarin (NPC2989) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
NCT00403767,NCT00262600,NCT02283294,NCT01518231,NCT00238667,NCT00027066,NCT00004728,NCT00041938
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT04887194,NCT01769768,NCT00091299,NCT01287598,NCT02422589,NCT02740712,NCT01517399
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
OR51E2,FABP5,FABP4,SMN1,TP53,GMNN,LMNA
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
NPC1,VKORC1,OR51E2,SMN1,GMNN,KLF5,LMNA
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
OR51E2,FABP5,FABP4,CYP19A1,GMNN,GMNN,CYP19A1
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
VKORC1
NCT04569279,NCT00643201,NCT01507051,NCT03747081,NCT03217448 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NCT02002611,NCT01103609,NCT00904176,NCT01432938,NCT02022254,NCT01147731
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
OR51E2,TP53,FABP5,GMNN,KLF5,LMNA
|
Pulmonary thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB00 |
VKORC1
NCT00062803,NCT00740883,NCT01516814,NCT04727437 |
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00345618,NCT01662908,NCT01516840,NCT03764241,NCT05208398
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
TP53,FABP5,CYP19A1,GMNN,KLF5
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
OR51E2,FABP5,FABP4,CYP19A1,GMNN
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
FABP5,CYP19A1,RAB9A,GMNN,LMNA
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
VKORC1,OR51E2,FABP5,CYP19A1,GMNN
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
FABP5,CYP19A1,FABP5,OR51E2
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
NPC1,KLF5,LMNA,OR51E2
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
FABP5,RAB9A,SMN1,GMNN
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT01911728,NCT04676035,NCT00004054
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NCT01311622,NCT01636557,NCT04246762
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
FABP5
NCT02772601,NCT02397382 |
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT01036802,NCT02238535,NCT04994119
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
TP53,FABP5,GMNN
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
KLF5,LMNA,CYP19A1
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT03839355,NCT01695824,NCT05006287,NCT02072434,NCT01227629,NCT00973323,NCT02164864,NCT02544932,NCT00262600,NCT02866175,NCT02450682,NCT00645853,NCT00070655,NCT01136408,NCT00742859,NCT00684307,NCT00494871,NCT00412984,NCT00938730,NCT00973245,NCT00403767,NCT00448214,NCT00580216
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT00265408,NCT02059785
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
FABP4
NCT04972396 |
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
NCT03147638,NCT00673439
|
Overactive bladderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50.0 |
NCT00856570,NCT00914667
|
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT00000614,NCT00125671
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT04865978,NCT00007683
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
NCT00041938,NCT02492230
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
NCT02169440,NCT02305030
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NCT03556592,NCT02647086
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
NCT00689637,NCT00726726
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00000614,NCT02303795
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
FABP5,OR51E2
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
GMNN,OR51E2
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
LMNA,RAB9A
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
FABP5,OR51E2
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
FABP5,GMNN
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
VKORC1,OR51E2
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
NCT00519207,NCT01503060,NCT01190995,NCT03082001,NCT01561547,NCT02174705,NCT03745963,NCT03272594,NCT01201954,NCT00482560,NCT02990364,NCT00949104
|
Venous thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD72 |
NCT00000614,NCT02331095,NCT00216866,NCT04066764,NCT01130025,NCT01006876,NCT00291330,NCT00329238,NCT00000614,NCT02913326,NCT00680186,NCT01505881
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
TP53
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RAB9A
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
TP53
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
TP53
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TP53
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
TP53
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TP53
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
TP53
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TP53
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
TP53
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
VKORC1
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
TP53
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TP53
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53
|
Supraventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81 |
VKORC1
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TP53
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CYP19A1
|
Coagulation defectDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B10 |
VKORC1
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TP53
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
VKORC1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
TP53
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
NCT03358706
|
ThrombocytosisDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B63 |
NCT00001713
|
HypertriglyceridaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.1 |
NCT01431690
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT03536208
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
NCT02086864
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT00180674
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT03718507
|
Macro reentrant atrial tachycardia, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.2Z |
NCT00412984
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT01758640
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NCT02070510
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000463
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT05445232
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01340846
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
NCT04855266
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT00004728
|
Late effects of cerebral ischemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B25.0 |
NCT00235248
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00041938
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT01263119
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT00404274
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT01462318
|
Retinopathy of prematurityDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71.3 |
NCT01238471
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
NCT03426033
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT03358706
|
Cerebral ischaemic stroke, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11.5Z |
NCT00004728
|
Antiphospholipid syndromeDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A45 |
NCT03684564
|
Preterm newborn, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA21.4Z |
NCT00218946
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
NCT00957242
|
Neoplasms of haematopoietic or lymphoid tissues, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B3Z |
NCT01317927
|
Transient ischaemic attackDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10 |
NCT00235248
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT04142658
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT02426060
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT04002011
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT00787059
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
NCT01388335
|
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT02287415
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
NCT00938132
|
Chronic rheumatic heart diseases, not elsewhere classifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC20 |
NCT02832544
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
KLF5
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CYP19A1
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
FABP4
|
Malignant neoplasms of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
FABP4
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
CYP19A1
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
FABP4
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
KLF5
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
FABP4
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
GMNN
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
KLF5
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
NPC1
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
FABP4
|